First Participant Enrolled in Second Cohort of BiondVax's Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine Trial

Stock Information for Scinai Immunotherapeutics Ltd Sponsed ADR (New)

Loading

Please wait while we load your information from QuoteMedia.